Eight Advisory assisted the management teams of Efor and Nodarius in the context of Efor’s acquisition of Nodarius

2023 will be another successful year for the Efor Group: on top of a 20% growth and in the aftermath of the reorganization of its shareholding structure, the leading consulting Group specialised in the life sciences sector has announced the acquisition of the Alsace-based Group Nodarius.

Founded in 2016, Nodarius has quickly become a major player in the life sciences consultancy market through its flagship brand, Altogen. The group is also active in the energy and mobility sectors via its Mealys and Emovia brands. With 450 employees in France and Switzerland, Nodarius has grown steadily since its inception, strengthening its position as a leading specialized consultancy and engineering player.

Now with a combined team of 2,500 experts and a growing presence in Europe, particularly in German-speaking Switzerland, the group headed by Mathieu Roger, Efor’s Chairman, aims to become a world leader in the life sciences consulting sector by 2028.

This transaction was supported by Efor’s shareholders consortium, including its long-time partner Raise Invest and its philanthropic fund “Investir pour l’enfance”, as well as Andera Acto. Additionally, Capza, a major player in growth capital and private debt for SMEs, has provided a Unitranche debt.

Pierre-David Forterre, Partner at Eight Advisory, commented : “We are proud to have assisted Efor and Nodarius in the context of this transaction, which marks a decisive change in the life sciences consulting landscape”.

Eight Advisory members supporting on this transaction :

• Pierre-David Forterre, Partner, and Christophe Delas, Partner